Get App
Download App Scanner
Scan to Download
Advertisement

Gaudium IVF and Women Health Lists At 5% Premium On Bourses — Check Key Details

Proceeds from the fresh issue will be directed toward establishing 19 new IVF centres across India, repaying debt, and meeting general corporate expenses.

Gaudium IVF and Women Health Lists At 5% Premium On Bourses — Check Key Details
  • Gaudium IVF debuted at Rs 83 per share, above its Rs 79 issue price
  • Shares rose nearly 10% post listing, then stabilised on BSE and NSE
  • The Rs 165-crore IPO included fresh and offer-for-sale equity shares
Did our AI summary help?
Let us know.

Gaudium IVF and Women Health made its market debut with a strong listing, opening at Rs 83 per share on both the BSE and NSE, compared to its issue price of Rs 79. The shares jumped as much as 10% after listing, stabilising post that. This is the sixth mainboard listing of this year.

The Rs 165‑crore public issue of Gaudium IVF was open for subscription from February 20 to February 24. The IPO allotment was finalised on February 25, and a BSE circular confirmed that Gaudium IVF and Women Health Limited will list and trade under the ‘T' Group of Securities.

The offering includes a fresh issue of 1.14 crore equity shares along with an offer for sale of about 95 lakh shares by promoter Manika Khanna. Proceeds from the fresh issue will be directed toward establishing 19 new IVF centres across India, repaying debt, and meeting general corporate expenses.

Retail investors could take part in the IPO by applying for one lot of 189 shares, which required an investment of Rs 14,931. For Small Non‑Institutional Investors (sNIIs), the minimum bid size was 14 lots, translating to an investment of Rs 2,09,034. Meanwhile, Large Non‑Institutional Investors (bNIIs) were required to apply for at least 67 lots, amounting to a commitment of Rs 10,00,377.

The IPO saw strong demand, recording a 7.27‑times subscription on the final day. According to NSE data, the issue received 10,63,50,489 bids against the 1,46,20,340 shares on offer. Interest varied across categories—

  • Non‑Institutional Investors (NIIs) subscribed 14.05 times,
  • Retail investors subscribed 7.60 times, and
  • Qualified Institutional Buyers (QIBs) subscribed 1.62 times.

Sarthi Capital Advisors Ltd. was the book running lead manager and Bigshare Services Ltd. was the registrar of the issue.

Gaudium IVF positions itself as a leading player in assisted reproductive technology in India, operating through a hub‑and‑spoke model featuring seven hubs and 28 spokes across multiple states.

ALSO READ: Stock Market News Today Live: Nifty Tests 25,350 Support, Sensex Down 300 Points; IT Stocks Gain

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search